Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
S. Luquero Bueno (Madrid, Spain), J. Galván-Román (Madrid, Spain), J. Curbelo (Madrid, Spain), M. Ortega-Gómez (Madrid, Spain), Á. Lancho-Sánchez (Madrid, Spain), L. Vega-Piris (Madrid, Spain), M. Gómez (Madrid, Spain), H. De La Fuente (Madrid, Spain), C. Suárez (Madrid, Spain), L. Jiménez-Borreguero (Madrid, Spain), J. Aspa Marco (Madrid, Spain)
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Luquero Bueno (Madrid, Spain), J. Galván-Román (Madrid, Spain), J. Curbelo (Madrid, Spain), M. Ortega-Gómez (Madrid, Spain), Á. Lancho-Sánchez (Madrid, Spain), L. Vega-Piris (Madrid, Spain), M. Gómez (Madrid, Spain), H. De La Fuente (Madrid, Spain), C. Suárez (Madrid, Spain), L. Jiménez-Borreguero (Madrid, Spain), J. Aspa Marco (Madrid, Spain). Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.. 2606
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: